3SBio fourth quarter total net revenues increase 38.


Total Calendar year 2011 Business Highlights Procedures EPIAO, the Company's flagship injectable recombinant human being erythropoietin item, demonstrated strong development with net revenues in 2011 growing 26.7 percent to RMB317.9 million , in comparison to RMB250.9 million in 2010 2010. Based on the most recent data from IMS Health China, EPIAO's market share with regards to worth reached 41.6 percent in the fourth quarter of 2011.Van Oudgaarden, M.D., Kitty W.M. Bloemenkamp, M.D., Ph.D., Dimitri N.M. Papatsonis, M.D., Ph.D., Ben Willem J. Mol, M.D., Ph.D., and Joris A.M. Van der Post, M.D., Ph.D.: Outcomes after Internal versus External Tocodynamometry for Monitoring Labor The monitoring of uterine contractions through internal tocodynamometry during induction or augmentation of labor is advocated by professional societies in obstetrics and gynecology. Induction or augmentation is essential in approximately 20 percent of most deliveries, and internal monitoring is considered to quantify the frequency, duration, and magnitude of uterine activity more accurately than does exterior tocography.1-3 The American College of Obstetricians and Gynecologists and the Society of Obstetricians and Gynaecologists of Canada advise the usage of inner tocodynamometry in selected circumstances, such as when the mother is certainly obese, when one-on-one nursing care is not available, or once the response to oxytocin is bound.